Triple
T5932617
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH M4 Common Technical Document |
E131971
|
entity |
| Predicate | adoptedBy |
P1034
|
FINISHED |
| Object |
Swissmedic
Swissmedic is the Swiss agency responsible for the authorization and supervision of therapeutic products, including medicines and medical devices, in Switzerland.
|
E555161
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Swissmedic | Statement: [ICH M4 Common Technical Document, adoptedBy, Swissmedic]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Swissmedic Context triple: [ICH M4 Common Technical Document, adoptedBy, Swissmedic]
-
A.
Federal Institute for Drugs and Medical Devices
The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Swiss Academy of Medical Sciences
The Swiss Academy of Medical Sciences is a leading Swiss institution that promotes excellence, ethics, and innovation in medical research and healthcare policy.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Swissmedic Triple: [ICH M4 Common Technical Document, adoptedBy, Swissmedic]
Generated description
Swissmedic is the Swiss agency responsible for the authorization and supervision of therapeutic products, including medicines and medical devices, in Switzerland.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Swissmedic Target entity description: Swissmedic is the Swiss agency responsible for the authorization and supervision of therapeutic products, including medicines and medical devices, in Switzerland.
-
A.
Federal Institute for Drugs and Medical Devices
The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
-
B.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
C.
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
D.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
E.
Swiss Academy of Medical Sciences
The Swiss Academy of Medical Sciences is a leading Swiss institution that promotes excellence, ethics, and innovation in medical research and healthcare policy.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c0085b75e88190a632f9691f9da48b |
completed | March 22, 2026, 3:18 p.m. |
| NER | Named-entity recognition | batch_69c0389df18c81909027a9db7596f0c1 |
completed | March 22, 2026, 6:44 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c0c064d2a4819096085668182cfde1 |
completed | March 23, 2026, 4:24 a.m. |
| NEDg | Description generation | batch_69c0c109b3288190928dc4539a2872c2 |
completed | March 23, 2026, 4:26 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c0c1f6fe60819080a00976740b6a9c |
completed | March 23, 2026, 4:30 a.m. |
Created at: March 22, 2026, 4 p.m.